Avricore Health Faces Going Concern Warning Amidst 89% Revenue Drop and Increased Losses

summarizeSummary

Avricore Health received a going concern warning from its auditor after reporting an 89% revenue decline and increased net losses in 2025, driven by the loss of a major customer. The company is strategically pivoting its HealthTab™ platform to the UK market to address these challenges.

check_boxKey Events

• Going Concern Warning Issued

  The company's auditor included an explanatory paragraph on going concern, citing recurring net losses and negative cash flows from operations, which raise substantial doubt about the company's ability to continue.

• Dramatic Revenue Decline in 2025

  Revenue decreased by 89% year-over-year to $533,884 in 2025, down from $4.79 million in 2024, primarily due to the non-renewal of an agreement with a major customer.

• Increased Net Loss and Cash Burn

  Net loss for 2025 widened to $1.86 million, compared to $668,977 in 2024. Cash and cash equivalents decreased by $904,474, ending the year at $227,918.

• Loss of Major Customer Impact

  The agreement with the company's major customer, which significantly contributed to 2024 revenue, expired on March 31, 2025, leading to substantial impairment losses on equipment and intangible assets totaling $493,544.

auto_awesomeAnalysis

The company's auditor issued a going concern warning due to recurring net losses and negative cash flows from operations, raising substantial doubt about its ability to continue. This follows an 89% year-over-year revenue decrease in 2025 to $533,884, primarily caused by the non-renewal of an agreement with a major customer. Net loss significantly widened to $1.86 million, and cash decreased by $904,474. The company is pivoting its HealthTab™ platform to the UK market, reporting initial pilot successes and a roadmap for expansion, but this strategy is set against a backdrop of severe financial distress.